Osteoporosis is typically considered as a disease of women; however, its incidence is increasing in men ([@bibr1-1557988319848219]; [@bibr16-1557988319848219]). In Japan, many women without symptoms are found to have reduced bone mass during medical examinations and the start of treatment. However, no such medical examinations are performed for men, who are often diagnosed as having osteoporosis only after a fracture ([@bibr23-1557988319848219]).

It is clear that the primary cause of osteoporosis in women is increased bone resorption and decreased bone density as a result of decreased estrogen secretion ([@bibr4-1557988319848219]; [@bibr17-1557988319848219]; [@bibr31-1557988319848219]). Meanwhile, testosterone aromatizes to estradiol in men as well. In adults, testosterone continues to stimulate periosteal growth, but estrogen is important in the structural maintenance of cancellous bone mass. Therefore, decreased estradiol levels in middle-aged and older men are reported to be associated with the risk of fracture as serum testosterone and estradiol levels decrease with age in men ([@bibr1-1557988319848219]; [@bibr27-1557988319848219]).

By contrast, osteoporosis and osteopenia are multifactorial diseases, and various lifestyle habits are involved in their development. The causes of osteoporosis in men include secondary factors such as decreased calcium absorption, decreased bone formation, alcohol drinking, and smoking, while the cause is unknown in half of the cases ([@bibr6-1557988319848219]; [@bibr12-1557988319848219]; [@bibr13-1557988319848219]; [@bibr14-1557988319848219]).

*Helicobacter pylori* is highly diverse genetically. *H. pylori* strains possessing the *cytotoxin-associated gene A* (*cagA*) are known to be the most virulent phenotype. [@bibr8-1557988319848219] reported that the prevalence of CagA-positive *H. pylori* infection was higher in men with osteoporosis than in healthy individuals in a case--control study involving 80 Italian men with and 160 men without osteoporosis ([@bibr8-1557988319848219]). In this report, increased levels of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin (IL)-6 in the patients with CagA-positive *H. pylori* infection may have affected bone resorption, and increases in urinary cross-laps, a bone resorption marker, may have contributed to the onset of osteoporosis. Moreover, as the genotype of *H. pylori* in Japan is almost solely the *cagA*-positive strain ([@bibr25-1557988319848219]), *H. pylori* infection may even have a closer association with decreased bone density in Japan than in the West. Furthermore, many reports highlighted the association between *H. pylori* infection and osteoporosis, mainly in East Asia and Japan ([@bibr2-1557988319848219]; [@bibr18-1557988319848219]; [@bibr19-1557988319848219]; [@bibr21-1557988319848219]). The East Asian type of *H. pylori* infection is considered to cause decreased gastric acid secretion as a result of gastric mucosal atrophy, thereby inhibiting the liberation of ionized calcium levels and causing decreased absorption. However, to date, no studies have simultaneously examined *H. pylori* infection and other important factors of osteoporosis, including estradiol level and calcium intake, in men.

To determine the relevant factors for the development of osteopenia in men, the present study investigated the association of *H. pylori* infection and gastric mucosal atrophy with decreased bone density in men together with estrogen level, calcium intake, and several lifestyle factors.

Methods {#section1-1557988319848219}
=======

Subjects {#section2-1557988319848219}
--------

The present study had a cross-sectional study design and included 268 healthy men (age range, 19--90 years; mean age: 49.1 ± 15.1 years) who underwent general medical examinations in the Iwaki area in Hirosaki City, Aomori Prefecture, in 2014. Details of the study flow of the subjects are outlined in [Figure 1](#fig1-1557988319848219){ref-type="fig"}. All the study subjects participated in response to a public announcement. The incidences of *H. pylori* infection and atrophic gastritis are particularly high in this region of Japan ([@bibr24-1557988319848219]). Patients with a history of *H. pylori* eradication, gastrectomy, proton pump inhibitor (PPI) use, receiving treatment for osteoporosis, or taking drugs that influence bone metabolism (e.g., steroids) were excluded from the study. We measured the bone density of the subjects and examined its association with age, body mass index (BMI), smoking habits, drinking habits, exercise habits, estradiol levels, daily calcium intake, and *H. pylori* infection and its associated gastric mucosal atrophy.

![Study flow of the subjects. A total of 268 subjects were enrolled from 442 healthy men who participated in general medical examinations.](10.1177_1557988319848219-fig1){#fig1-1557988319848219}

The target sample size was 211 when the significance level was 5% and the statistical power was 80%. The final sample size of the study was 268, and the power of this analysis was calculated as 91.6%.

Measurement of Bone Density {#section3-1557988319848219}
---------------------------

The AOS-100NW Bone Densitometer, which uses quantitative ultrasonography (QUS) at the calcaneus, was used to measure bone density ([@bibr3-1557988319848219]). Osteo sono assessment index (OSI) scores were measured, and subjects with a T-score of ≤−1.0 SD (based on a comparison with the mean OSI score of young people \[20--44 years\]) were defined as having osteopenia in accordance with the World Health Organization diagnostic criteria ([@bibr13-1557988319848219]).

Serum and Stool Samples {#section4-1557988319848219}
-----------------------

*H. pylori* infection was diagnosed by testing for serum anti-*H. pylori* immunoglobulin G (IgG) antibodies and stool *H. pylori* antigens. The enzyme immunoassay (EIA) kit E-plate (Eiken Chemical Co., Ltd. Tokyo, Japan) was used to test for serum anti-*H. pylori* (IgG) antibodies with an antibody titer of ≥10 U/ml as positive and \<3 U/ml as negative. Those whose test results were ≥3 and \<10 U/ml were excluded, as they tended to be false negatives and infection was difficult to diagnose accurately ([@bibr5-1557988319848219]). Those who tested negative for *H. pylori* infection but had a suspected gastric mucosal atrophy were excluded, as they were likely to have a past infection. *H. pylori* antigen levels in stool samples were measured using Testmate Pylori Antigen EIA (Wakamoto Co., Ltd, Tokyo, Japan; Kyowa Medex Co., Ltd, Tokyo, Japan). The subjects whose antibodies and antigen test results matched were classified as infected or uninfected, and those for whom the results did not match were excluded from the study. Serum levels of pepsinogens (PGs) were measured simultaneously. Participants with PG I levels of \<70 ng/ml and PG I/II levels of \<3.0 ng/ml were excluded because of the suspicion of gastric mucosal atrophy and the likelihood of a past *H. pylori* infection, even if the subjects were negative for both serum anti-*H. pylori* IgG antibodies and stool *H. pylori* antigens ([@bibr5-1557988319848219]).

As for estrogen levels, estradiol is a metabolite of testosterone with the strongest effect and, thus, was measured in this study. The reference range for men is 20--60 pg/ml and \<20 pg/ml was considered low.

Questionnaire and Interviews {#section5-1557988319848219}
----------------------------

Interviews concerning lifestyle habits were also conducted. Questionnaires were sent to all participants prior to the general medical examinations. The subjects brought the questionnaire themselves on the day of the examination and the answers were confirmed by more than a dozen investigators in one-to-one interviews. Smoking and drinking habits were categorized as present, past, or none. Exercise habits were defined as the presence of periodic exercise at least once per week over the course of a year.

The brief-type self-administered diet history questionnaire (BDHQ) was distributed to the subjects, and daily calcium intake was calculated on the basis of 1-month food menus. On the basis of the Dietary Reference Intakes for Japanese 2015 recommended by the Japanese Ministry of Health, Labour and Welfare (MHLW), low calcium intake was defined as levels below the recommended intake of 650 mg/day.

Statistical Analyses {#section6-1557988319848219}
--------------------

SPSS version 24.0J (SPSS Inc., Chicago, IL, USA) was used for data management and analysis. A univariate analysis was used to compare age, BMI, smoking habit, drinking habit, exercise habit, estradiol level, daily calcium intake, and *H. pylori* infection and associated gastric mucosal atrophy between the two groups (osteopenia and non-osteopenia groups). A multivariate analysis was also performed, with age, BMI, smoking habit, drinking habit, exercise habit, estradiol level, calcium intake, and *H. pylori* infection and its associated gastric mucosal atrophy as the independent variables and the presence of osteopenia as the dependent variable. The adjusted odds ratio (OR) was calculated on the basis of the multiple logistic regression analysis.

Study Approval {#section7-1557988319848219}
--------------

The present study was a joint project conducted by the Iwaki District of Hirosaki City and Hirosaki University Graduate School of Medicine. The study was approved by the Hirosaki University institutional review board (approval No. 2014-377). All the subjects who participated in health examinations as part of the project received an explanation of the details of the examination and principal aims of the study. Written consent was obtained prior to study commencement.

Results {#section8-1557988319848219}
=======

The results of the comparison and univariate analysis of each factor related to the presence/absence of osteopenia are shown in [Table 1](#table1-1557988319848219){ref-type="table"}. Osteopenia was identified in 57 (21.3%) of the 268 subjects. Significant differences in age, BMI, smoking habit, and calcium intake were found in the univariate analysis when the groups with and without osteopenia were compared.

###### 

The Subject's Background and Univariate Analysis for Each Factor Related to Presence of Osteopenia.

![](10.1177_1557988319848219-table1)

                                              Total            Osteopenia (WHO diagnostic criteria)   *p*                               
  ----------------------- ------------------- ---------------- -------------------------------------- ----------------- ------ -------- --------
  Age (years old)         Mean ± *SD*         49.1 ± 15.2      48.0 ± 14.9                            53.3 ± 15.0       .019            
                          (range)             (19--90)         (19--90)                               (23--83)                          
                          ≤50 years old       152              127                                    (83.6)            25     (16.4)   .027
                          \>50 years old      116              84                                     (72.4)            32     (27.6)   
  BMI (kg/m^2^)           Mean ± *SD*         23.7 ± 3.3       23.9 ± 3.3                             23.0 ± 3.3        .065            
                          (Range)             (17.2--36.3)     (17.2--36.3)                           (17.6--33.0)                      
                          \<18.5              8                3                                      (37.5)            5      (62.5)   \<.001
                          18.50--24.99        188              144                                    (76.6)            44     (23.4)   
                          ≥25.0               72               64                                     (88.9)            8      (11.1)   
  Smoking                 Nonsmoker           95               81                                     (85.3)            14     (14.7)   .047
                          Current smoker      84               59                                     (70.2)            25     (29.8)   
                          Past smoker         89               71                                     (79.8)            18     (20.2)   
  Alcohol                 Nondrinker          70               55                                     (78.6)            15     (21.4)   .209
                          Current drinker     187              145                                    (77.5)            42     (22.5)   
                          Past drinker        11               11                                     (100.0)           0      (0.0)    
  Exercise habit          Irregular           191              150                                    (78.5)            41     (21.5)   .901
                          Periodical          77               61                                     (79.2)            16     (20.8)   
  Estradiol level         Median              20               20                                     19                                
                          (Range)             (\<10--71)       (\<10--71)                             (\<10--45)                        
                          Normal              167              130                                    (77.8)            37     (22.2)   .648
                          Low                 101              81                                     (80.2)            20     (19.8)   
  Calcium intake          Mean ± *SD*         502.7 ± 245.9    490.9 ± 228.6                          546.3 ± 300.0     .132            
                          (Range)             (91.4--1632.3)   (91.4--1632.3)                         (139.7--1593.1)                   
                          Normal              54               48                                     (88.9)            6      (11.1)   .041
                          Low                 214              163                                    (76.2)            51     (23.8)   
  *H. pylori* infection   Negative            185              148                                    (80.0)            37     (20.0)   .282
                          Positive                                                                                                      
                          Mucosal atrophy--   44               36                                     (81.8)            8      (18.2)   
                          Mucosal atrophy+    39               27                                     (69.2)            12     (30.8)   

*Note*. BMI = body mass index; WHO = World Health Organization.

[Table 2](#table2-1557988319848219){ref-type="table"} shows the results of the multiple logistic regression analysis with each item as an adjustment item. With regard to *H. pylori* infection and gastric mucosal atrophy in relation to osteopenia, the adjustment ORs were 0.74 (95% CI \[0.29, 1.90\]; *p* = .531) and 1.31 (95% CI \[0.54, 3.21\], *p* = .552) when *H. pylori* infection was positive without and with atrophy, respectively. *H. pylori* infection and gastric mucosal atrophy were not significant factors. Estradiol level had an adjustment OR of 0.87 (95% CI \[0.45, 1.67\], *p* = .680) and was also not a significant factor. Among the lifestyle factors, higher BMI was negatively associated with osteopenia, but both current smoking and low calcium intake were positively associated with osteopenia.

###### 

Multiple Logistic Regression Analysis for Each Factor Related to Presence of Osteopenia.

![](10.1177_1557988319848219-table2)

                                                         *n*   Adjusted odds ratio   *p*
  ----------------------- ------------------------------ ----- --------------------- ------
  Age                     ≤50 years old                  152   1                     
                          \>50 years old                 116   1.85 \[0.92, 3.72\]   .086
  BMI                     \<18.5                         8     1                     
                          18.50--24.99                   188   0.15 \[0.03, 0.73\]   .019
                          ≥25.0                          72    0.07 \[0.01, 0.38\]   .002
  Smoking                 Nonsmoker                      95    1                     
                          Current smoker                 84    2.34 \[1.04, 5.28\]   .041
                          Past smoker                    89    1.40 \[0.61, 3.19\]   .426
  Alcohol                 Nondrinker                     70    1                     
                          Current drinker                187   0.85 \[0.41, 1.77\]   .851
                          Past drinker                   11    --                    \-
  Exercise habit          Irregular                      191   1                     
                          Periodical                     77    1.26 \[0.41, 1.77\]   .530
  Estradiol level         Normal                         167   1                     
                          Low                            101   0.87 \[0.45, 1.67\]   .680
  Calcium intake          Normal                         54    1                     
                          Low                            214   2.92 \[1.09, 7.81\]   .034
  *H. pylori* infection   Negative                       185   1                     
                          Positive (mucosal atrophy--)   44    0.74 \[0.29, 1.90\]   .531
                          Positive (mucosal atrophy+)    39    1.31 \[0.54, 3.21\]   .552

*Note.* BMI = body mass index.

Discussion {#section9-1557988319848219}
==========

The results of the present study indicated that the factors associated with osteopenia in Japanese men were low BMI, smoking, and low calcium intake. Meanwhile, no significant association was found with *H. pylori* infection, gastric mucosal atrophy, or estradiol level.

In a study of osteoporosis in Japanese men, *H. pylori* significantly increased the risk of low trabecular bone density (TBD), and gastric mucosal atrophy significantly increased the risk of low TBD and low elastic modulus of the trabecular bone in 230 men in their 50s and 60s ([@bibr21-1557988319848219]). The possible mechanisms and etiology of osteoporosis caused by *H. pylori* infection include bone resorption due to a systemic reaction in addition to a local reaction caused by inflammatory cytokines (IL-1, IL-6, IL-8, TNF-α, etc.) ([@bibr2-1557988319848219]; [@bibr18-1557988319848219]; [@bibr19-1557988319848219]; [@bibr21-1557988319848219]). Decreased acid secretion due to gastric mucosal atrophy associated with *H. pylori* infection is assumed to inhibit the liberation of ionized calcium and to lead to decreased absorption ([@bibr2-1557988319848219]; [@bibr18-1557988319848219]; [@bibr19-1557988319848219]; [@bibr21-1557988319848219]). Many reports have been published on the association between low-acid environments with the internal use of PPIs and osteoporosis as a result of a similar mechanism ([@bibr15-1557988319848219]; [@bibr22-1557988319848219]). In other words, virulent *H. pylori* infection, such as that with East Asian--type CagA, spreads to the gastric body at an early stage, leads to widespread gastric mucosal atrophy as a result of severe long-term active gastritis, reduces the number of parietal cells distributed in the fundic gland region, and decreases gastric acid secretion in many cases ([@bibr9-1557988319848219]). In the present study, no significant association was found between gastric mucosal atrophy caused by *H. pylori* infection and decreased bone density. The reason for this could be that calcium absorption levels were relatively well maintained owing to the mild decrease in gastric acid secretion as compared with that with internal use of PPIs. In addition, severe low-acid environments were avoided even if the degree of gastric mucosal atrophy may have been severe. *H. pylori* infection was diagnosed using only serum anti-*H. pylori* antibodies in studies that reported an association between *H. pylori* infection and osteoporosis. In many cases, diagnosis using serum anti-*H. pylori* antibodies may include current and past infections even at levels below the cutoff value ([@bibr5-1557988319848219]; [@bibr30-1557988319848219]). It has come to be known that when setting the cutoff value at 10 U/ml for the E-plates in anti-*H. pylori* IgG antibody assay kits, which are widely used in Japan, nearly 20% of patients with antibody titers of ≥3 and \<10 U/ml will include those who have past or current infection ([@bibr5-1557988319848219]). The results of the present study may have been different from those of previous reports because *H. pylori* infection was strictly defined by excluding patients with anti-*H. pylori* antibody titers of ≥3 and \<10 U/ml and by evaluating atrophy with stool antigen tests and PG.

The results of the multivariate analysis showed that decreased bone density in men was associated with low BMI, smoking habit, and daily calcium intake. The association of low BMI with the increased risk of osteoporotic fractures has also been observed ([@bibr6-1557988319848219]; [@bibr20-1557988319848219]). reported that regardless of age, sex, and race, for each 1-kg/m^2^ increase in BMI, the proximal femoral bone density increased by 0.0082 g/cm^3^ ([@bibr20-1557988319848219]). Low BMI was also a significant risk factor for osteopenia in the present study. The importance of weighting and muscle strength in maintaining and increasing bone density was again demonstrated in this study.

Smoking is considered a risk factor for osteoporosis, as it induces antiestrogen action, suppression of calcium absorption through the intestinal tract, blood flow disorder, vascular disorder, and arteriosclerosis. Several meta-analysis studies have been conducted on the risk of fracture due to smoking ([@bibr11-1557988319848219]; [@bibr28-1557988319848219]). However, in men the risk ratio (RR) of femoral proximal fracture was 1.82 for current smokers in reference to those who have never smoked and 1.11 for former smokers, which shows no significant difference and suggests the efficacy of smoking cessation ([@bibr11-1557988319848219]). The OR of current smokers was 2.34 in relation to those who have never smoked, while that of past smokers was 1.40, with no significant difference. These results also suggest increased bone density as a result of smoking cessation.

Low daily calcium intake was also a significant factor of osteopenia. Reports indicated that calcium intake is significantly associated with bone mass and bone density in men ([@bibr13-1557988319848219]; [@bibr29-1557988319848219]). The results of the 2017 National Health and Nutrition Survey report indicated that the average daily intake of calcium is 520 mg in men in Japan, which is lower than the reference amount of 650 mg. Only 10.5% of the subjects in the osteopenia group and 22.7% of the subjects in the non-osteopenia group exceeded the reference value in the present study. Absorption of calcium relies on active transport mediated by active vitamin D and concentration-dependent passive transport. It increases in proportion to calcium intake ([@bibr7-1557988319848219]; [@bibr26-1557988319848219]). Rather than considering the absorption rate of calcium, including decreased acid secretion, increasing calcium intake itself may be more effective for preventing osteopenia in Japanese men, whose calcium intake is often below the reference value.

Estradiol level was not a significant factor of reduced bone density in men. Estrogen directly suppresses bone resorption by osteoclasts, but it also suppresses osteoclast differentiation by suppressing the expression of the receptor activator of nuclear factor kappa-Β ligand ([@bibr17-1557988319848219]; [@bibr31-1557988319848219]). Serum estradiol levels are higher in elderly men than in postmenopausal women and show stronger associations with bone mineral density, bone turnover, and bone loss than testosterone levels ([@bibr1-1557988319848219]; [@bibr16-1557988319848219]; [@bibr27-1557988319848219]). Evidence regarding estradiol level shows a threshold value at which male bone impairment occurs. Bone maturation is delayed in men below the threshold value as a result of increased speed of bone mass decrease and fracture rate ([@bibr27-1557988319848219]). In the present study, the receiver operating characteristic curve for estradiol for evaluating the optimal threshold value was examined, but the area under the curve was too small (0.573) to calculate the optimal threshold value (data not shown).

This study has several limitations. One limitation is that the present study was a cross-sectional study. Another limitation is that the association between the degree of atrophy in individuals with *H. pylori* infection and gastric pH was not elucidated. The relationship between the presence/absence of atrophy as detected using the PG test method and the degree of gastric pH is unclear. Although gastric pH is impossible to monitor in all subjects, good correlation has been shown between serum PG level and gastric acid secretion level ([@bibr10-1557988319848219]). Furthermore, we excluded subjects with past *H. pylori* infection because serum PG levels are significantly modulated by the eradication of *H. pylori* infection. The third limitation is that bone density was measured using the calcaneal QUS, which is a more standardized and widely used tool than hip and spinal dual-energy x-ray absorptiometry (DXA). One of the reasons is that the general medical examinations in this study were performed at a public facility where DXA was not available, rather than at a medical institution. Another reason is the exposure to radiation.

In conclusion, low BMI, smoking habit, and daily calcium intake were associated with decreased bone density in the Japanese men in this study. Decreased bone density was not associated with *H. pylori* infection and *H. pylori--*associated gastric mucosal atrophy or estradiol level. The results of the present study are different from those of previous reports because *H. pylori* infection was defined more strictly and several original confounding factors were simultaneously evaluated.

**Declaration of Conflicting Interests:** The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

**Funding:** This study was partly supported by JSPS KAKENHI Grant Number 17K09098 & 26460761. This study was based on the Iwaki Health Promotion Project as a project by Hirosaki University Graduate School of Medicine, in collaboration with Aomori Heath Evaluation and Promotion Center and Hirosaki City Office, Department of Health Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

**ORCID iD:** Daisuke Chinda ![](10.1177_1557988319848219-img1.jpg) <https://orcid.org/0000-0003-1690-5923>

Tadashi Shimoyama ![](10.1177_1557988319848219-img1.jpg) <https://orcid.org/0000-0001-9615-0000>
